Emergency Use Authorizations for Drugs and Non-Vaccine Biological Products
Similar Posts
17th Annual Sentinel Initiative Public Workshop – 11/06/2025
The U.S. Food and Drug Administration, under a cooperative agreement with the Duke-Margolis Institute for Health Policy, is hosting the 16th Annual Sentinel Initiative Public Workshop on November 6, 2025LiquidCapsule Manufacturing, LLC – 717069 – 12/19/2025
CGMP/Finished Pharmaceuticals/AdulteratedExtended-Release Stimulants for ADHD: FDA Drug Safety Communication – FDA Requires Expanded Labeling about Weight Loss Risk in Patients Younger than 6 Years
The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including certain formulations of amphetamine and methylphenidate – to warn about the risk of weight loss and other adverse reactions (side effects) in patients yoWithdrawn and Expired Guidances | Drugs
Withdrawn and Expired Guidances | DrugsGastrointestinal Drugs Advisory Committee Roster
This page contains the Gastrointestinal roster, which lists the current members and the current number of vacancies for the committee.INFORMED CONSENT TEMPLATE FOR INDIVIDUAL PATIENT EXPANDED ACCESS
INFORMED CONSENT TEMPLATE FOR INDIVIDUAL PATIENT EXPANDED ACCESS